Insights

Spatialomics Leadership Rebus Biosystems offers a fully automated, integrated instrument for spatial omics with subcellular resolution, presenting a compelling upsell to labs seeking end-to-end spatial analysis solutions.

Robust Partnerships Recent collaborations with Rosalind, Inc. to co-develop spatial omics software indicate openness to ecosystem partnerships, suggesting sales opportunities through integrated software and platform beacons for broader customer bases.

Venture Backing Illumina Ventures-backed status, along with rapid executive hires in HR and finance, signals strong growth momentum and potential for larger institutional purchases and multi-site deployments as the company scales.

Academic Validation Publication of a Science study showcasing vascular cell diversity mapping using Rebus Esper strengthens credibility with academic and translational research buyers who require validated, publication-backed tools.

Service‑Oriented Model Spatial Omics as a Service program and on-system chemistry integrated with software present a compelling model for customers seeking accelerated ROI without heavy upfront instrumentation investment.

Rebus Biosystems Tech Stack

Rebus Biosystems uses 8 technology products and services including HubSpot Analytics, Esper, Microsoft 365, and more. Explore Rebus Biosystems's tech stack below.

  • HubSpot Analytics
    Analytics
  • Esper
    Devops
  • Microsoft 365
    Email
  • jQuery Migrate
    Javascript Libraries
  • SharpSpring
    Marketing Automation
  • Priority Hints
    Performance
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics

Media & News

Rebus Biosystems's Email Address Formats

Rebus Biosystems uses at least 1 format(s):
Rebus Biosystems Email FormatsExamplePercentage
FLast@rebusbio.comJDoe@rebusbio.com
96%
Last@rebusbio.comDoe@rebusbio.com
4%

Frequently Asked Questions

What is Rebus Biosystems's official website and social media links?

Minus sign iconPlus sign icon
Rebus Biosystems's official website is rebusbio.com and has social profiles on LinkedInCrunchbase.

How much revenue does Rebus Biosystems generate?

Minus sign iconPlus sign icon
As of August 2026, Rebus Biosystems's annual revenue is estimated to be $1M - $10M.

What is Rebus Biosystems's SIC code NAICS code?

Minus sign iconPlus sign icon
Rebus Biosystems's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Rebus Biosystems have currently?

Minus sign iconPlus sign icon
As of August 2026, Rebus Biosystems has approximately 8 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer President: V. R.Chief Financial Officer: E. W.Manager, Systems Engineering: S. K.. Explore Rebus Biosystems's employee directory with LeadIQ.

What industry does Rebus Biosystems belong to?

Minus sign iconPlus sign icon
Rebus Biosystems operates in the Biotechnology Research industry.

What technology does Rebus Biosystems use?

Minus sign iconPlus sign icon
Rebus Biosystems's tech stack includes HubSpot AnalyticsEsperMicrosoft 365jQuery MigrateSharpSpringPriority HintsBootstrapGoogle Analytics.

What is Rebus Biosystems's email format?

Minus sign iconPlus sign icon
Rebus Biosystems's email format typically follows the pattern of FLast@rebusbio.com. Find more Rebus Biosystems email formats with LeadIQ.

How much funding has Rebus Biosystems raised to date?

Minus sign iconPlus sign icon
As of August 2026, Rebus Biosystems has raised $38M in funding. The last funding round occurred on Nov 03, 2022 for $18M.
Rebus Biosystems logo

Rebus Biosystems

Biotechnology ResearchCalifornia, United States2-10 Employees

Rebus Biosystems develops tools for spatial omics research, enabling subcellular resolution of biological molecules within large tissue sections. The platform supports customizable assays and ships as an automated, integrated instrument introduced for laboratories in early 2021, with access also available through a Spatial Omics as a Service program. Based in Santa Clara, California, the company targets research laboratories pursuing detailed tissue-level molecular maps. It positions itself in the spatial omics field by integrating imaging, on-system chemistry, and software to support end-to-end workflows. A notable development is a 2022 collaboration with Rosalind, Inc. to co-develop spatial omics software.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $38M

    Rebus Biosystems has raised a total of $38M of funding over 2 rounds. Their latest funding round was raised on Nov 03, 2022 in the amount of $18Mas a series_unknown.

  • $1M - $10M

    Rebus Biosystems's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $38M

    Rebus Biosystems has raised a total of $38M of funding over 2 rounds. Their latest funding round was raised on Nov 03, 2022 in the amount of $18Mas a series_unknown.

  • $1M - $10M

    Rebus Biosystems's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.